Publications Archive - KalVista Pharmaceuticals

Presentations & Publications

We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.

Apply Reset

Topic

Forum

Year

Apply Reset

Showing 2 out of 2

Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.

Simao F, Ustunkaya T, Clermont AC, and Feener EP.
Blood. 2017.
PMID:28130211

Plasma kallikrein mediates angiotensin AT1 receptor stimulated retinal vascular permeability.

Phipps JA, Clermont AC, Sinha S, Chilcote TJ, Bursell S-E, and Feener EP.
Hypertension 2009; 53:175-81.
PMID:19124682

About